MDMA transiently alters biogenic amines and metabolites in mouse brain and heart (original) (raw)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

Michael Baumann

Psychopharmacology, 2006

View PDFchevron_right

(±)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats

David Mokler

European Journal of Pharmacology, 1987

View PDFchevron_right

MDMA-induced neurotoxicity: long-term effects on 5HT biosynthesis and the influence of ambient temperature

Verónica Inés Sánchez

British Journal of Pharmacology, 2006

View PDFchevron_right

Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse

James Woods

Psychopharmacology, 2005

View PDFchevron_right

MDMA and the Brain: A Short Review on the Role of Neurotransmitters in ...

Basic and Clinical Neuroscience Journal

Basic and Clinical Neuroscience, 2020

View PDFchevron_right

Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, “ECSTASY”) and its potential to damage brain serotonin neurons

george ricaurte

Neurotoxicity Research, 2001

View PDFchevron_right

A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration

Mahalakshmi Shankaran

Psychopharmacology, 1999

View PDFchevron_right

MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment

Bertha Madras

Psychopharmacology, 2006

View PDFchevron_right

A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

Verónica Inés Sánchez

British Journal of Pharmacology, 2001

View PDFchevron_right

MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor

Bertha Madras

Journal of Psychopharmacology, 2008

View PDFchevron_right

3,4-Methylenedioxymethamphetamine (MDMA) administration induces alterations in rat electroretinogram

Claudia Cavadas

Frontiers in Neuroscience, 1970

View PDFchevron_right

Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)

Michael Baumann

International review of neurobiology, 2009

View PDFchevron_right

Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys

M. Kleven

View PDFchevron_right

The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT synthesis rate in the rat brain: an autoradiographic study

D. Mück-seler

Brain Research, 1998

View PDFchevron_right

Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons

Gary Gudelsky

Pharmacology Biochemistry and Behavior, 2008

View PDFchevron_right

A comparative study on the acute and long-term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice

Verónica Inés Sánchez

British Journal of Pharmacology, 2005

View PDFchevron_right

Serotonergic Neurotoxicity of MDMA (Ecstasy) in the Developing Rat Brain

Jerrold Meyer

Annals of the New York Academy of Sciences, 2006

View PDFchevron_right

Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity

Una McCann

Synapse, 2011

View PDFchevron_right

Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity

Jesse Brodkin

Pharmacology Biochemistry and Behavior, 1993

View PDFchevron_right

Major metabolites of(±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

george ricaurte

Brain Research, 1991

View PDFchevron_right

Relevance of MDMA (\ecstasy\)-induced neurotoxicity to long-lasting psychomotor stimulation in mice

Yossef Itzhak

2003

View PDFchevron_right

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

george ricaurte

Addiction, 1994

View PDFchevron_right

Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men

Yossef Itzhak

IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), 2004

View PDFchevron_right

Initial deficit and recovery of function after MDMA preexposure in rats

Susan Schenk

Psychopharmacology, 2006

View PDFchevron_right

Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats

Francesca Fernandez

European Journal of Neuroscience, 2002

View PDFchevron_right

The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity

Aaron Janowsky

Neurotoxicology and teratology, 2017

View PDFchevron_right

In vitro neuronal and vascular responses to 5‐HT in rats chronically exposed to MDMA

Dara M Cannon

British journal of …, 2001

View PDFchevron_right

MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release

Efrain Azmitia

Brain Research, 1990

View PDFchevron_right

Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity

Jerrold S Meyer

Journal of Neurochemistry, 2010

View PDFchevron_right